Pharmacodynamic effect of IMCgp100 (TCR CD3 bispecific) on peripheral cytokines and association with overall survival in patients with advanced melanoma
Authors
Middleton, MRSteven, NM
Evans, TRJ
Infante, JR
Hamid, O
Shoushtari, AN
Corrie, PG
Anthoney, A
Gupta, Avinash
Woodcock, VK
McAlpine, C
Sznol, M
Affiliation
Churchill Hospital, OxfordIssue Date
2019
Metadata
Show full item recordCitation
Middleton MR, Steven NM, Evans TRJ, Infante JR, Hamid O, Shoushtari AN, et al. Pharmacodynamic effect of IMCgp100 (TCR�CD3 bispecific) on peripheral cytokines and association with overall survival in patients with advanced melanoma. J Clin Oncol. 2019;37(15_suppl):9523-.Journal
Journal of Clinical OncologyDOI
10.1200/JCO.2019.37.15_suppl.9523Additional Links
https://dx.doi.org/10.1200/JCO.2019.37.15_suppl.9523Type
Meetings and ProceedingsLanguage
enae974a485f413a2113503eed53cd6c53
10.1200/JCO.2019.37.15_suppl.9523